Filing Summary
Business Context and Reporting Period
EUDA Health Holdings Limited filed a Form 6-K dated July 3, 2023, covering the month of July 2023. The filing confirms that the company qualifies as a foreign private issuer under Rule 3b-4 of the Exchange Act and has begun reporting under the Exchange Act as a foreign private issuer.
Financial and Operating Metrics
This filing does not provide financial statements, revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
Material Changes Versus Prior Period
The filing does not report material changes in financial or operating performance. Its principal disclosure is the company’s transition to foreign private issuer reporting on Forms 20-F and 6-K.
Guidance, Outlook, Risks, and Unusual Items
No guidance, outlook, management discussion, specific risks, contingencies, or unusual financial items are disclosed. The company states that it will file future annual reports on Form 20-F and furnish future current reports on Form 6-K.
Investor Verification Items
- Verify the company’s subsequent Form 20-F and Form 6-K filings for financial results and material developments.
- Confirm the effective scope and timing of the company’s foreign private issuer reporting obligations.
- Review later filings for revenue, profitability, cash position, debt, liquidity, and any disclosed risks or contingencies.